S.Amdt. 2402
What it does: Adds SEC. 722. COMPTROLLER GENERAL OF THE UNITED STATES REPORT ON AVAILABILITY OF COMPOUNDED PHARMACEUTICALS IN THE MILITARY HEALTH CARE SYSTEM at the end of subtitle C of title VII
Sen. Lindsey Graham (R-SC)What it changes
1 change to S. 1197 · shown in the bill's text
Adds SEC. 722. COMPTROLLER GENERAL OF THE UNITED STATES REPORT ON AVAILABILITY OF COMPOUNDED PHARMACEUTICALS IN THE MILITARY HEALTH CARE SYSTEM at the end of subtitle C of title VII
Adds a sectionIn S. 1197 · Placed on Calendar Senate
(2) the Committee on Armed Services and the Committee on Veterans' Affairs of the House of Representatives.
Inserted: SEC. 722. COMPTROLLER GENERAL OF THE UNITED STATES REPORT ON AVAILABILITY OF COMPOUNDED PHARMACEUTICALS IN THE MILITARY HEALTH CARE SYSTEM.
Inserted: (a) Report Required.--Not later than September 30, 2014, the Comptroller General of the United States shall submit to Congress a report on the availability of compounded pharmaceuticals in the military health care system.
Inserted: (b) Elements.--The report required by subsection (a) shall include the following:
Inserted: (1) A description of the number of prescriptions for compounded pharmaceuticals processed, and the types of compounded pharmaceuticals dispensed, in military medical treatment facilities and through the mail order and retail venues of the pharmacy benefits program of the TRICARE program in fiscal year 2013.
Inserted: (2) A description of the categories of eligible beneficiaries who received compounded pharmaceuticals in each pharmacy venue of the military health care system in fiscal year 2013.
Inserted: (3) A description of the claims reimbursement methodology used by the manager of the pharmacy benefits program to reimburse pharmacy providers for compounded pharmaceuticals, and an assessment of the manner in which such methodology compares with reimbursement methodologies used by other major public programs and private insurers.
Inserted: (4) An estimate of potential cost savings for the Department of Defense if the manager of the pharmacy benefits program used an alternative claims reimbursement methodology for compounded pharmaceuticals provided under the pharmacy benefits program.
Inserted: (5) A review of the accreditation standards and options intended to assure the safety and efficacy of compounded pharmaceuticals available through the military health care system.
Original wording
At the end of subtitle C of title VII, add the following:
Read automatically from the Congressional Record. Check the original before relying on it.
As printed
SA 2402. Mr. GRAHAM submitted an amendment intended to be proposed by him to the bill S. 1197, to authorize appropriations for fiscal year 2014 for military activities of the Department of Defense, for military construction, and for defense activities of the Department of Energy, to prescribe military personnel strengths for such fiscal year, and for other purposes; which was ordered to lie on the table; as follows:
At the end of subtitle C of title VII, add the following:
SEC. 722. COMPTROLLER GENERAL OF THE UNITED STATES REPORT ON AVAILABILITY OF COMPOUNDED PHARMACEUTICALS IN THE MILITARY HEALTH CARE SYSTEM.
(a) Report Required.--Not later than September 30, 2014, the Comptroller General of the United States shall submit to Congress a report on the availability of compounded pharmaceuticals in the military health care system.
(b) Elements.--The report required by subsection (a) shall include the following:
(1) A description of the number of prescriptions for compounded pharmaceuticals processed, and the types of compounded pharmaceuticals dispensed, in military medical treatment facilities and through the mail order and retail venues of the pharmacy benefits program of the TRICARE program in fiscal year 2013.
(2) A description of the categories of eligible beneficiaries who received compounded pharmaceuticals in each pharmacy venue of the military health care system in fiscal year 2013.
(3) A description of the claims reimbursement methodology used by the manager of the pharmacy benefits program to reimburse pharmacy providers for compounded pharmaceuticals, and an assessment of the manner in which such methodology compares with reimbursement methodologies used by other major public programs and private insurers.
(4) An estimate of potential cost savings for the Department of Defense if the manager of the pharmacy benefits program used an alternative claims reimbursement methodology for compounded pharmaceuticals provided under the pharmacy benefits program.
(5) A review of the accreditation standards and options intended to assure the safety and efficacy of compounded pharmaceuticals available through the military health care system.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment submitted
November 20, 2013